Thursday, March 22, 2012

TEVA - New Position

A new CSP position was established today on Teva Pharmaceutical Industries Ltd (TEVA). All prices include IB commissions.

Dividend Champions StatusContender
Years of Consecutive Dividend Increases13
Fair Value Estimate$58.00
Target Buy Price$40.60
Target Margin of Safety30.00%
Actual Buy Price$40.00
Actual Margin of Safety31.03%

DateStockDescriptionTransactionStatusStock InvestmentIncome Generated
3/22/2012TEVACSP Margin UsedCSP 100 TEVA @ 40.00 ($4,000.00) 
3/22/2012TEVAInitial Put OptionSTO 1 May12 40.00 Put @ 0.51  $50.97

Position Summary

Cost Basis($4,000.00)
Income Generated$50.97
Percent Income Generated1.27%
Annualized Income Generated8.16%
Net Profit If Assigned$50.97
Percent Return If Assigned1.27%
Annualized Return If Assigned8.16%
Days Held to Expiration57 days